Search - tctmd.com

Displaying 181 - 200 of 1207

Sort: Relevancy | Date

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

The Transformative Potential of Digital Health Strategies to Impact Clinical Research and Patient Outcomes

Presenter: Ami Bhatt

September 19, 2022

Presentation TCT 2022

The PERT Effect: How to Establish a Multdisciplinary Care Team for PE

Presenter: Sanjum Sethi

September 19, 2022

Presentation TCT 2022

Strengths and Limitations of Patient Reported Outcomes as Major Endpoints in "Modern Era" CV Trials

Presenter: Alexander Iribarne

September 19, 2022

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

Presentation TCT 2022

What Do the Guidelines Say?

Presenter: Celina Yong

September 19, 2022

Presentation TCT 2022

Come With Me If You Want to Survive: The Future of AI in Cardiology

Presenter: Pierre Elias

September 19, 2022

Not Yet – We Still Need Clinical Outcomes Data

Presentation TCT 2022

That’s Great But We Still Need Clinical Outcomes Data

Presenter: Ajay J. Kirtane

September 18, 2022

Presentation TCT 2022

It’s Time We Had These Devices Approved and Reimbursed

Presenter: David E. Kandzari

September 18, 2022

Presentation TCT 2022

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

Presenter: C. Michael Gibson

September 18, 2022

Presentation TCT 2022

Health Equity Issues in Clinical Trials: Can We Accelerate Progress?

Presenter: Clyde Yancy

September 18, 2022

Presentation TCT 2022

Regulatory Innovation Revisited: Blending Patient Needs, Industry Imperatives, Health Policy, and Reimbursement

Presenter: Aaron Kaplan

September 18, 2022

Presentation TCT 2022

FDA Recovering From a Pandemic: Lessons Learned and Future Adjustments

Presenter: William Maisel

September 18, 2022

News Conference News TCT 2022

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

L.A. McKeown

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

Presentation TCT 2022

FDA Update on EFS Requirements for TTVR Technologies

Presenter: Kevin G. Soucy

September 17, 2022

Presentation TCT 2022

From Bench to Preclinical: Key Tests and Considerations

Presenter: Torsten P. Vahl

September 17, 2022

Presentation TCT 2022

None Use: The Data Are Unconvincing and the Cost Is Prohibitive

Presenter: David J. Cohen

September 17, 2022

Presentation TCT 2022

Selective Use: Only in Vulnerable Patients

Presenter: John K. Forrest

September 17, 2022

Advertisement

SCAAR Registry Delves Into Left Main Revascularization Outcomes

The Transformative Potential of Digital Health Strategies to Impact Clinical Research and Patient Outcomes

The PERT Effect: How to Establish a Multdisciplinary Care Team for PE

Strengths and Limitations of Patient Reported Outcomes as Major Endpoints in "Modern Era" CV Trials

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

What Do the Guidelines Say?

Come With Me If You Want to Survive: The Future of AI in Cardiology

That’s Great But We Still Need Clinical Outcomes Data

It’s Time We Had These Devices Approved and Reimbursed

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

Health Equity Issues in Clinical Trials: Can We Accelerate Progress?

Regulatory Innovation Revisited: Blending Patient Needs, Industry Imperatives, Health Policy, and Reimbursement

FDA Recovering From a Pandemic: Lessons Learned and Future Adjustments

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

FLASH: More Data to Support Mechanical Thrombectomy in PE

FDA Update on EFS Requirements for TTVR Technologies

From Bench to Preclinical: Key Tests and Considerations

None Use: The Data Are Unconvincing and the Cost Is Prohibitive

Selective Use: Only in Vulnerable Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content